Javascript must be enabled to continue!
Design and Characterisation of Poly(lactide-co-glycolide) Small Particulate Systems for the Delivery of Immunostimulant CpG Oligonucleotide
View through CrossRef
The aim of this study was to develop and characterize biodegradable small particles of poly(lactide-co-glycolide) (PLGA) as oral vehicle for immunostimulatory oligonucleotide (ODN-CpG). Three different polymers were used as surface stabilizing agents (SSA): polyvinyl alcohol (PVA),
hydrophobically modified hydroxyethylcellulose (HMHEC), or polyethylenimine (PEI). Particle surface was characterized as well as ODN-CpG release kinetics. All particles were found to be around 1 μ. Particles of PLGA-PVA and PLGA-HMHEC were spherical in shape with a smooth surface
whereas PLGA-PEI particles were porous. The presence of ODN-CpG within the particle matrix was confirmed in all particle type using scanning laser confocal microscopy. Particle surface assayed by XPS, zeta potential analysis, and evaluation of particle surface hydrophobicity suggested that
a significant amount of SSA remains associated onto particle surface. Release profiles evidenced that ODN-CpG release was strongly dependent on particle surface properties. 100% of encapsulated ODN-CpG was released from PLGA-PVA and PLGA-HMHEC particles 37 days after incubation in a buffer
solution, whereas only 25% were released from PLGA-PEI particles. ODN-CpG can therefore be nicely entrapped in several types of small particles displaying a prolonged and controlled release upon time. In addition, particle surface is not modified by the presence of ODN-CpG.
American Scientific Publishers
Title: Design and Characterisation of Poly(lactide-co-glycolide) Small Particulate Systems for the Delivery of Immunostimulant CpG Oligonucleotide
Description:
The aim of this study was to develop and characterize biodegradable small particles of poly(lactide-co-glycolide) (PLGA) as oral vehicle for immunostimulatory oligonucleotide (ODN-CpG).
Three different polymers were used as surface stabilizing agents (SSA): polyvinyl alcohol (PVA),
hydrophobically modified hydroxyethylcellulose (HMHEC), or polyethylenimine (PEI).
Particle surface was characterized as well as ODN-CpG release kinetics.
All particles were found to be around 1 μ.
Particles of PLGA-PVA and PLGA-HMHEC were spherical in shape with a smooth surface
whereas PLGA-PEI particles were porous.
The presence of ODN-CpG within the particle matrix was confirmed in all particle type using scanning laser confocal microscopy.
Particle surface assayed by XPS, zeta potential analysis, and evaluation of particle surface hydrophobicity suggested that
a significant amount of SSA remains associated onto particle surface.
Release profiles evidenced that ODN-CpG release was strongly dependent on particle surface properties.
100% of encapsulated ODN-CpG was released from PLGA-PVA and PLGA-HMHEC particles 37 days after incubation in a buffer
solution, whereas only 25% were released from PLGA-PEI particles.
ODN-CpG can therefore be nicely entrapped in several types of small particles displaying a prolonged and controlled release upon time.
In addition, particle surface is not modified by the presence of ODN-CpG.
Related Results
Limited expression of non-integrating CpG-free plasmid is associated with increased nucleosome enrichment
Limited expression of non-integrating CpG-free plasmid is associated with increased nucleosome enrichment
CpG-free pDNA was reported to facilitate sustained transgene expression with minimal inflammationin vivoas compared to CpG-containing pDNA. However, the expression potential and im...
T Cell Modulation Combined with Intratumoral CpG Cures Lymphoma without the Need for Chemotherapy.
T Cell Modulation Combined with Intratumoral CpG Cures Lymphoma without the Need for Chemotherapy.
Abstract
Introduction: We have previously shown that intratumoral injection of CpG oligodeoxynucleotide plus systemic chemotherapy can induce T cell immunity against...
Liposome-Encapsulated CpG Oligodeoxynucleotides as a Potent Adjuvant for Inducing Type 1 Innate Immunity
Liposome-Encapsulated CpG Oligodeoxynucleotides as a Potent Adjuvant for Inducing Type 1 Innate Immunity
AbstractUnmethylated cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG-ODNs) exhibit potent immunostimulating activity by binding with Toll-like receptor 9 (TLR9) expres...
Prediction model construction of mouse stem cell pluripotency using CpG and non-CpG DNA methylation markers
Prediction model construction of mouse stem cell pluripotency using CpG and non-CpG DNA methylation markers
AbstractBackgroundGenome-wide studies of DNA methylation across the epigenetic landscape provide insights into the heterogeneity of pluripotent embryonic stem cells (ESCs). Differe...
Bioinformatics Unravels the Epigenetic Mechanisms of Hashimoto’s Thyroiditis: Deciphering Molecular Complexity
Bioinformatics Unravels the Epigenetic Mechanisms of Hashimoto’s Thyroiditis: Deciphering Molecular Complexity
ABSTRACT
Introduction
Recent research in the field of epigenetics has shed light on the impact of epigenetic modifications in t...
CpG motifs in bacterial DNA evokes peroxynitrite signaling in human neutrophils
CpG motifs in bacterial DNA evokes peroxynitrite signaling in human neutrophils
Bacterial DNA is emerging as an important regulator of functions of human neutrophil granulocytes. Bacterial DNA contains short sequences of nonmethylated CpG dinucleotides (CpG‐DN...
Évolution des îlots CpG chez les primates
Évolution des îlots CpG chez les primates
Cette thèse a pour l’objet l’étude des pressions de sélection qui s’appliquent sur les îlots CpG, courtes séquences génomiques qui échappent à la méthylation chez les mammifères. N...
CpG-ODN 2007 protects zebrafish against
Vibrio vulnificus
-induced infection
CpG-ODN 2007 protects zebrafish against
Vibrio vulnificus
-induced infection
Abstract
Vibrio vulnificus (V. vulnificus)
is an aquatic pathogen that can cause primary sepsis and soft tissue infection. CpG ...

